BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 7, 2008
View Archived Issues
Apoptos Targeting Cell Death with $28M Series A Financing
Year-old Apoptos Inc. is raising $28 million in its first major funding round since being established in June 2007 by venture firms Venrock and ARCH Ventures based on technology targeting programmed cell death. (BioWorld Today)
Read More
FDA Panel Advises Against Wider Marketing of Fentora
Read More
New Data on MedImmune, AVI BioPharma RSV Drugs
Read More
Merck Cost-Cutting Could Be Boon for Biotech Firms
Read More
Pfizer Pullout Sends NicOx Shares Down
Read More
Other News To Note
Read More
Clinic Roundup
Read More